DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Januvia (Sitagliptin) - Current Clinical Trials

 
 



Januvia Related Clinical Trials

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals [Recruiting]

The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects [Recruiting]

A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211) [Not yet recruiting]

Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes [Recruiting]

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105) [Recruiting]

A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229) [Recruiting]

A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266) [Recruiting]

Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function [Recruiting]

Sitagliptin in Renal Transplant Recipients [Recruiting]

Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus [Recruiting]

Sitagliptin in Prevention of Type 2 Diabetes Mellitus [Not yet recruiting]

DPP4 Inhibitor in the Hospital [Not yet recruiting]

Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260) [Not yet recruiting]

A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296) [Recruiting]

Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome [Recruiting]

Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans [Recruiting]

Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083) [Recruiting]

A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus [Not yet recruiting]

A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1) [Recruiting]

A Study of LY2189265 and Sitagliptin in Patients With Type 2 Diabetes [Recruiting]

A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289 AM2) [Not yet recruiting]

Treatment of Diabetes After Gastric Bypass With Sitagliptin [Not yet recruiting]

Januvia Re-examination Study (MK-0431-181 AM3) [Recruiting]

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus (0431-251) [Recruiting]

Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes [Recruiting]

Sitagliptin Cardiovascular Outcome Study (0431-082 AM1) [Recruiting]

MK-3102 Phase III Clinical Trial - Placebo- and Sitagliptin-controlled Monotherapy Study in Japanese Participants With Type 2 Diabetes Mellitis (MK-3102-020) [Recruiting]

Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users [Not yet recruiting]

Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy [Recruiting]

Pharmacogenetics of Ace Inhibitor-Associated Angioedema [Recruiting]

Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea [Recruiting]

Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121) [Recruiting]

Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases [Recruiting]

A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes [Recruiting]

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253) [Recruiting]

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254) [Recruiting]

Sitagliptin in the Elderly [Recruiting]

Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination Compared to Glimepiride in Patients With Type 2 Diabetes Mellitus (MK-0431A-202 AM2) [Recruiting]

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents [Recruiting]

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (0431-130) [Recruiting]

Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure [Recruiting]

DPP-4 Inhibition and TZD for DM Prevention [Recruiting]

Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263) [Recruiting]

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial) [Recruiting]

Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction [Recruiting]

Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass [Recruiting]

A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes [Recruiting]

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and a Thiazolidinedione in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2) [Recruiting]

MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus [Recruiting]

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus [Recruiting]

Sitagliptin (MK0431) Versus Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone [Recruiting]

Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes [Recruiting]

Sitagliptin Added-on to Insulin Study [Recruiting]

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin [Recruiting]

Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With Type 2 Diabetes Mellitus (T2DM) [Not yet recruiting]

Beta-Cell Function and Sitagliptin Trial (BEST) [Recruiting]

A Study of the Effects of Co-Administration of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations [Recruiting]

Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant [Recruiting]

Comparison of the Effect of Exenatide Versus Sitagliptin on 24-Hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione [Not yet recruiting]

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus [Recruiting]

Comparative Study of MK0431A in Patients With Type 2 Diabetes [Recruiting]

Sitagliptin in Combination With Metformin and Sulfonylurea [Recruiting]

Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency [Recruiting]

The Effect of Sitagliptin in T2DM With Inadequate Glycemic Control [Recruiting]

Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease [Recruiting]

ALPHA Sitagliptin Add on to Metformin [Recruiting]

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus [Recruiting]

Beta-Cell Function in Glucose Abnormalities and Acute Myocardial Infarction [Recruiting]

Bone Turnover in Type 2 Diabetes Patients [Recruiting]

A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin. [Recruiting]

MK0431A Comparative Study in Patients With Type 2 Diabetes [Recruiting]

A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes [Recruiting]

Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome [Recruiting]

18-Week Add-on to Metformin Comparison of Saxagliptin and Sitagliptin [Recruiting]

Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes [Recruiting]

The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation [Recruiting]

A Study of LY2189265 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus on Metformin [Recruiting]

Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan [Recruiting]

Effects of Sitagliptin on Gastric Emptying in Healthy Subjects [Not yet recruiting]

Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients [Recruiting]

Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus [Not yet recruiting]

A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin. [Recruiting]

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibitin-Mediated Enhancement of the Activity of the Entero-Insular Axis [Not yet recruiting]

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) [Recruiting]

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus [Recruiting]

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress [Recruiting]

Incretin Effect and Use After Clinical Islet Transplantation [Recruiting]

Incretins in Impaired Fasting Glucose [Recruiting]

Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency [Recruiting]

How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin. [Recruiting]

Effects of Glutamine on GLP-1 and Insulin Secretion in Man [Recruiting]

BI 10773 add-on to Metformin in Patients With Type 2 Diabetes [Recruiting]

Response To Oral Agents in Diabetes (ROAD)- Pilot Study [Not yet recruiting]

The Effect of BI 1356 on 24h-Glucose Control and Various Biomarkers in Type 2 Diabetic Patients [Not yet recruiting]

An Efficacy, Safety, and Tolerability Study for JNJ-28431754 in Patients With Type 2 Diabetes. [Recruiting]

Long Term Effects of DPP-IV Inhibitor Treatment on the Secretion and Action of Incretin Hormones in Patients With Type 2 Diabetes [Recruiting]

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin [Not yet recruiting]

A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs. [Recruiting]

Journey for Control of Diabetes Study [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012